1 |
MacFarland S, Bagatell R. Advances in neuroblastoma therapy[J]. Curr Opin Pediatr, 2019, 31(1): 14-20.
|
2 |
Haas-Kogan DA, Swift PS, Selch M, et al. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study[J]. Int J Radiat Oncol Biol Phys, 2003, 56(1): 28-39.
|
3 |
Valteau-Couanet D, Michon J, Boneu A, et al. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol[J]. J Clin Oncol, 2005, 23(3): 532-540.
|
4 |
Liu KX, Naranjo A, Zhang FF, et al. Prospective evaluation of radiation dose escalation in patients with high-risk neuroblastoma and gross residual disease after surgery: a report from the children′s oncology group ANBL0532 study[J]. J Clin Oncol, 2020, 38(24): 2741-2752.
|
5 |
Arumugam S, Manning-Cork NJ, Gains JE, et al. The evidence for external beam radiotherapy in high-risk neuroblastoma of childhood: a systematic review[J]. Clin Oncol (R Coll Radiol), 2019, 31(3): 182-190.
|
6 |
Matthay KK, Haas-Kogan D, Constine LS. Neuroblastoma[M]//Halperin EC, Constien LS, Tarbell NJ, et al. Pediatric radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2011: 108-136.
|
7 |
Oberthuer A, Berthold F, Warnat P, et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification[J]. J Clin Oncol, 2006, 24(31): 5070-5078.
|
8 |
Canete A, Gerrard M, Rubie H, et al. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience[J]. J Clin Oncol, 2009, 27(7): 1014-1019.
|
9 |
de Ioris MA, Crocoli A, Contoli B, et al. Local control in metastatic neuroblastoma in children over 1 year of age[J]. BMC Cancer, 2015, 15: 79.
|
10 |
范洪君, 黄程, 苏雁, 等. 伴骨髓转移的高危神经母细胞瘤患儿临床特征及预后分析[J]. 中华儿科杂志, 2019, 57(11): 863-869.
|